Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Global Market Report 2025
상품코드:1810875
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
데옥시리보 핵산(DNA) 복구 알킬화제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.1%로 성장할 전망이며, 50억 5,000만 달러로 성장이 예측됩니다. 예측 기간 동안의 성장은 맞춤형 의료 및 DNA 복구를 표적으로 한 치료법의 채용 증가, 임상 검사의 파이프라인 확대, 노인 종양학에 대한 주목 증가, 화학요법의 동반 진단약의 성장, 희소암에 대한 정부 조성의 강화 등에 기인할 것으로 보입니다. 이 기간에 예상되는 주요 동향으로는 표적 DNA 복구 억제제로의 전환, 이중 작용 화학요법제의 개발, 알킬화제 탐색에서 AI의 통합, 확립된 알킬화제의 바이오시밀러의 성장, 치료 선택을 개선하기 위한 바이오마커의 이용 등이 있습니다.
세계적인 암 이환율 증가가 DNA 복구 알킬화제 시장의 향후 성장을 견인할 것으로 예측됩니다. 암은 신체의 특정 세포가 통제 불능으로 증식하기 시작하고 이웃 조직과 신체의 다른 부분으로 전이 할 수있는 질병입니다. 세계적인 암 환자 증가는 암을 발병할 위험이 높은 고령화가 주요 원인입니다. DNA 복구 알킬화제는 급속하게 분열하는 종양 세포의 DNA에 손상을 주고 증식을 저지함으로써 암을 치료합니다. 이 손상은 세포 사멸과 증식 억제를 초래하고 종양 진행을 억제하는 데 도움이 됩니다. 예를 들어 2024년 2월 스위스에 본부를 둔 정부간 기관인 세계보건기구(WHO)는 2022년 세계에서 약 2,000만 명이 새롭게 암으로 진단되어 970만 명이 사망했다고 보고했습니다. 게다가 암으로 진단된 후 5년 이내에 생존했던 것은 추정 5,350만 명이었습니다. 따라서 세계적인 암 이환율 증가가 DNA 복구 알킬화제 시장의 성장을 가속하고 있습니다.
DNA 복구 알킬화제 시장의 주요 기업은 안전성 프로파일을 향상시키면서 치료 효과를 개선하고 치료 대상의 암 범위를 넓히기 위해 나이트로젠 겨자를 기반으로 한 약물과 같은 고급 치료법의 개발에 주력하고 있습니다. 나이트로젠 머스타드계 약제는 알킬화제이며, DNA를 가교함으로써 암세포를 사멸시켜 복제를 저해합니다. 이 약은 백혈병과 림프종의 암 화학 요법에서 일반적으로 사용됩니다. 예를 들어, 2022년 11월, 인도에 본사를 둔 제약 회사인 Alembic Pharmaceuticals는 미국 식품의약국(USFDA)으로부터 25mg 및 50mg의 강도로 입수할 수 있는 시클로포스파미드 캡슐의 약식 신약 승인 신청(ANDA)에 대한 최종 승인을 받았습니다. 이 알킬화제는 다양한 악성 종양과 소아 환자의 minimal change nephrotic syndrome의 치료에 적응합니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 성장률 분석
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 실적 : 규모 및 성장(2019-2024년)
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 제품 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
질소 머스타드
니트로소우레아
알킬술폰산염
트리아진
기타
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
암 치료
연구개발
기타
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
연구기관
제약회사
기타
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 질소 머스타드 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
메크로레타민
시클로포스파미드
이호스파미드
클로람부실
멜파란
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 니트로소우레아 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
칼무스틴(BCNU)
롬스틴(CCNU)
스트렙토조신
셈스틴
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 알킬설폰산염 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
부술팬
트레오술판
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 트리아진류 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
다카르바진
테모졸로미드
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 기타 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
치오테파
프로카르바진
벤담스틴
루루비넥테진
제7장 지역별 및 국가별 분석
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 경쟁 구도
데옥시리보 핵산(DNA) 복구 알킬화제 시장 : 기업 프로파일
Bristol-Myers Squibb Company : 개요, 제품 및 서비스, 전략 및 재무 분석
Teva Pharmaceutical Industries Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Baxter International : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi : 개요, 제품 및 서비스, 전략 및 재무 분석
Intas Pharmaceuticals : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Dr. Reddy's Laboratories
Aurobindo Pharma
Hikma Pharmaceuticals
Amneal Pharmaceuticals
Alembic Pharmaceuticals Limited
Natco Pharma Ltd
Medac GmbH
Celon Laboratories
Azurity Pharmaceuticals
Meitheal Pharmaceuticals Inc
Acrotech Biopharma
Navinta LLC
STI Pharma LLC
Emcure Pharmaceuticals
Halsted Pharma Pvt. Ltd.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
데옥시리보 핵산(DNA) 복구 알킬화제 시장(2029년) : 새로운 기회를 제공하는 국가
데옥시리보 핵산(DNA) 복구 알킬화제 시장(2029년) : 새로운 기회를 제공하는 부문
데옥시리보 핵산(DNA) 복구 알킬화제 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
A deoxyribonucleic acid (DNA) repair alkylating agent is a chemotherapy drug that attaches alkyl groups to DNA molecules, causing damage that disrupts the cancer cell's ability to replicate and survive. These agents create covalent bonds with DNA, resulting in cross-linking or mispairing of DNA bases, which can lead to cell cycle arrest or apoptosis if the damage remains unrepaired.
The main categories of DNA repair alkylating agents include nitrogen mustards, nitrosoureas, alkyl sulfonates, triazines, and others. Nitrogen mustards are powerful bifunctional alkylating agents widely used in cancer treatment, though they are also associated with side effects such as skin damage, inflammation, and potential carcinogenic risks. These agents have applications in cancer therapy, research and development, and other fields, and are utilized by end users like hospitals, research institutions, pharmaceutical companies, and more.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.
The deoxyribonucleic acid (DNA) repair alkylating agents market research report is one of a series of new reports from The Business Research Company that provides deoxyribonucleic acid (DNA) repair alkylating agents market statistics, including the deoxyribonucleic acid (DNA) repair alkylating agents industry global market size, regional shares, competitors with the deoxyribonucleic acid (DNA) repair alkylating agents market share, detailed deoxyribonucleic acid (DNA) repair alkylating agents market segments, market trends, opportunities, and any further data you may need to thrive in the deoxyribonucleic acid (DNA) repair alkylating agents industry. This deoxyribonucleic acid (DNA) repair alkylating agents market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The deoxyribonucleic acid (DNA) repair alkylating agent market size has grown strongly in recent years. It will grow from $3.41 billion in 2024 to $3.70 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth during the historic period can be attributed to the rising number of hospitals and specialized cancer treatment clinics, increased regulatory approvals of various alkylating agents, expanded healthcare access in developing regions, enhanced cancer awareness initiatives by governments and NGOs, and the broader adoption of chemotherapy treatments.
The deoxyribonucleic acid (DNA) repair alkylating agent market size is expected to see strong growth in the next few years. It will grow to $5.05 billion in 2029 at a compound annual growth rate (CAGR) of 8.1%. The projected growth in the forecast period can be attributed to the rising adoption of personalized medicine and DNA repair-targeted therapies, an expanding pipeline of clinical trials, increased focus on geriatric oncology, the growth of companion diagnostics for chemotherapy, and enhanced government funding for rare cancers. Key trends anticipated during this period include a move toward targeted DNA repair inhibitors, the development of dual-action chemotherapy agents, the integration of AI in the discovery of alkylating drugs, growth in biosimilars of established alkylating agents, and the use of biomarkers to improve treatment selection.
The increasing prevalence of cancer cases worldwide is expected to drive the growth of the DNA repair alkylating agent market moving forward. Cancer is a disease in which certain cells in the body begin to grow uncontrollably and may spread to nearby tissues or other parts of the body. The global rise in cancer cases is largely due to aging populations, who face a higher risk of developing cancer. DNA repair alkylating agents treat cancer by damaging the DNA of rapidly dividing tumor cells, thereby preventing their multiplication. This damage results in cell death or growth inhibition, helping to control tumor progression. For example, in February 2024, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, reported that approximately 20 million new cancer cases were diagnosed in 2022, with 9.7 million deaths worldwide. Additionally, an estimated 53.5 million people were alive within five years after a cancer diagnosis. Therefore, the global increase in cancer prevalence is fueling growth in the DNA repair alkylating agent market.
Key companies in the DNA repair alkylating agent market are focusing on developing advanced therapies such as nitrogen mustard-based drugs to improve treatment effectiveness and broaden the range of cancers treated while enhancing safety profiles. Nitrogen mustard drugs are alkylating agents that kill cancer cells by cross-linking their DNA, thus blocking replication. These drugs are commonly used in chemotherapy for cancers like leukemia and lymphoma. For instance, in November 2022, Alembic Pharmaceuticals, an India-based pharmaceutical firm, received final approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for cyclophosphamide capsules, available in 25 mg and 50 mg strengths. This alkylating agent is indicated for treating various malignancies as well as minimal change nephrotic syndrome in pediatric patients.
In June 2024, Dr. Reddy's Laboratories USA, a US-based pharmaceutical manufacturer involved in producing drugs including anticancer alkylating agents, partnered with Ingenus Pharmaceuticals LLC to expand access to quality cancer treatments. This collaboration aims to increase the availability of cyclophosphamide injection in the U.S. market by combining Ingenus's manufacturing capabilities with Dr. Reddy's strong distribution network. Ingenus Pharmaceuticals LLC is a US-based producer of affordable generic medications offering cost-effective solutions for patients.
Major players in the deoxyribonucleic acid (dna) repair alkylating agent market are Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Limited, Baxter International, Fresenius Kabi, Intas Pharmaceuticals, Dr. Reddy's Laboratories, Aurobindo Pharma, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Alembic Pharmaceuticals Limited, Natco Pharma Ltd, Medac GmbH, Celon Laboratories, Azurity Pharmaceuticals, Meitheal Pharmaceuticals Inc, Acrotech Biopharma, Navinta LLC, STI Pharma LLC, Emcure Pharmaceuticals, Halsted Pharma Pvt. Ltd., MSN Pharmaceuticals, Jiangsu Hengrui Pharmaceuticals Co. Ltd.
North America was the largest region in the deoxyribonucleic acid (DNA) repair alkylating agent market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in deoxyribonucleic acid (DNA) repair alkylating agent report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the deoxyribonucleic acid (DNA) repair alkylating agent market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The deoxyribonucleic acid (DNA) repair alkylating agent market consists of sales of ethylenimines and methylmelamines, hydrazines, aziridines, and procarbazine. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on deoxyribonucleic acid (dna) repair alkylating agent market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for deoxyribonucleic acid (dna) repair alkylating agent ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The deoxyribonucleic acid (dna) repair alkylating agent market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Nitrogen Mustards; Nitrosoureas; Alkyl Sulfonates; Triazines; Other Product Types
2) By Application: Cancer Treatment; Research And Development; Other Applications
3) By End-User: Hospitals; Research Institutes; Pharmaceutical Companies; Other End-Users
Subsegments:
1) By Nitrogen Mustards: Mechlorethamine; Cyclophosphamide; Ifosfamide; Chlorambucil; Melphalan
2) By Nitrosoureas: Carmustine (BCNU); Lomustine (CCNU); Streptozocin; Semustine
3) By Alkyl Sulfonates: Busulfan; Treosulfan
4) By Triazines: Dacarbazine; Temozolomide
5) By Other Product Types: Thiotepa; Procarbazine; Bendamustine; Lurbinectedin
4. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Growth Analysis And Strategic Analysis Framework
5.1. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
6.1. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nitrogen Mustards
Nitrosoureas
Alkyl Sulfonates
Triazines
Other Product Types
6.2. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer Treatment
Research And Development
Other Applications
6.3. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Research Institutes
Pharmaceutical Companies
Other End-Users
6.4. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Nitrogen Mustards, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mechlorethamine
Cyclophosphamide
Ifosfamide
Chlorambucil
Melphalan
6.5. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Nitrosoureas, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Carmustine (BCNU)
Lomustine (CCNU)
Streptozocin
Semustine
6.6. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Alkyl Sulfonates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Busulfan
Treosulfan
6.7. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Triazines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Dacarbazine
Temozolomide
6.8. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Thiotepa
Procarbazine
Bendamustine
Lurbinectedin
7. Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market Regional And Country Analysis
7.1. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Deoxyribonucleic Acid (DNA) Repair Alkylating Agent Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
